US endocrine review supports low-dose effects theory

A US expert panel on endocrine disrupting compounds has concluded that low-dose effects "have been clearly demonstrated" for some oestrogenic compounds. However, it says that more research is needed on the disputed issue of low-dose effects from exposure to the plastics intermediate bisphenol A.

Sorry you do not have access to this article. Please contact Customer Support at
report@ends.co.uk
or call 020 8267 8120